相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
Lukmanee Tradtrantip et al.
FASEB JOURNAL (2012)
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
Puay-Wah Phuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
NMDA Receptor Antibody Encephalitis
Sarosh R. Irani et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays
Jonathan M. Crane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Aquaporins at a glance
Alan S. Verkman
JOURNAL OF CELL SCIENCE (2011)
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Angela Vincent et al.
LANCET NEUROLOGY (2011)
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
Romain Marignier et al.
BRAIN (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes
John D. E. Parratt et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Development trends for human monoclonal antibody therapeutics
Aaron L. Nelson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
New Convenient Four-Component Synthesis of 6-Amino-2,4-dihydropyrano[2,3-c]pyrazol-5-carbonitriles and One-Pot Synthesis of 6′-Aminospiro[(3H)-indol-3,4′-pyrano[2,3-c]pyrazol]-(1H)-2-on-5′-carbonitriles
Yuri M. Litvinov et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2009)
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
B. O. Khatri et al.
NEUROLOGY (2009)
PIGS: automatic prediction of antibody structures
Paolo Marcatili et al.
BIOINFORMATICS (2008)
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
Bruce Cree
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2008)
SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling
Qiang Wang et al.
NATURE PROTOCOLS (2008)
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
S. R. Hinson et al.
NEUROLOGY (2007)
Synthesis and molluscicidal activity of new cinnoline and pyrano [2,3-c]pyrazole derivatives
Fathy M. Abdelrazek et al.
ARCHIV DER PHARMAZIE (2006)
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
Nicolas Foloppe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
JL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)